logo
Forever Chemicals In Your Closet? How PFAS May Be Harming Your Health

Forever Chemicals In Your Closet? How PFAS May Be Harming Your Health

Forbes18-05-2025

In the pursuit of performance, the fashion industry has quietly adopted a class of synthetic chemicals that offer stain resistance, water repellency and durability. But the price may be higher than advertised.
Per- and polyfluoroalkyl substances, collectively known as PFAS, are increasingly found in clothing, from yoga leggings to hiking jackets and activewear. Dubbed "forever chemicals" because they don't naturally break down, PFAS persist in our environment and bodies, raising urgent questions about their long-term effect on human and planetary health and safety.
Initially developed in the mid-20th century, PFAS are now ubiquitous in consumer goods, including personal care products, nonstick cookware, food packaging and water-resistant fabrics. In the apparel industry, they're often applied as coatings to make clothes repel water, oil, and dirt, which is convenient for outdoor gear and athletic wear, but at an environmentally hidden expense.
According to a 2022 report by Toxic-Free Future, 72% of products labeled as water- or stain-resistant contained detectable levels of PFAS. These findings align with independent studies, such as one published in Environmental Science & Technology Letters, which found PFAS in multiple mainstream apparel brands, including some marketed as "green" or "eco-conscious."
While PFAS aren't absorbed through the skin as easily as they are ingested, research suggests that chronic, low-level exposure from clothing still contributes to a person's overall toxic burden. That's because PFAS can break down over time, entering the Air as dust, lingering on skin, and washing into water systems, where they accumulate in the environment and human tissue. Here's what the science shows:
Endocrine Disruption
Immune System Suppression
Increased Cancer Risk
Metabolic and Cardiovascular Effects
Reproductive and Developmental Toxicity
This growing body of evidence has prompted researchers to frame PFAS exposure not as an isolated risk, but as a chronic environmental stressor that interacts with other economic and sociocultural issues, including diet, air pollution and systemic health issues.
As scientific awareness grows, so does public pressure. U.S. states like California and New York are leading the way by implementing bans on intentionally added PFAS in textiles, beginning with outerwear and expanding into broader apparel categories. The European Union is considering a comprehensive ban on PFAS in all consumer goods under its REACH regulatory framework.
Still, industry resistance persists. Many apparel brands cite durability and supply chain complexity as reasons for the slow adoption of sustainable practices. Despite the highly complex nature of this worldwide topic, alternatives exist, including wax-based coatings, bio-based repellents, and PFAS-free membranes.
While systemic change is paramount, informed consumer choices remain a powerful force. Here's how to reduce PFAS exposure through your wardrobe:
The comfort of stain-free leggings or rainproof jackets might not be worth the cost to our long-term human and planetary health. As consumers, scientists and changemakers start to challenge the invisible risks woven into our clothes, the fashion industry faces a crucial inflection point: choose short-term performance or long-term responsibility.
Certainly, what we wear is about expression, but also exposure and a more profound commitment to our overall well-being.

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Body fat predicts major health risk that BMI misses, researchers say
Body fat predicts major health risk that BMI misses, researchers say

Fox News

time27 minutes ago

  • Fox News

Body fat predicts major health risk that BMI misses, researchers say

Body mass index (BMI) may not be the most accurate predictor of death risk. A new study from the University of Florida found that BMI — a measurement that is commonly used to determine whether a person's weight is in a healthy range for their height — is "deeply flawed" in terms of predicting mortality. Instead, one's level of body fat is "far more accurate," concluded the study, which was published this week in the Annals of Family Medicine. To measure participants' body fat, the researchers used a method called bioelectrical impedance analysis (BIA), which uses a device to measure the resistance of body tissue to a small electrical current. Over a 15-year period, those who had high body fat were found to be 78% more likely to die than those who had healthy body fat levels, researchers found. They were also more than three times as likely to die of heart disease, the study noted. BMI — which is calculated by dividing weight by height, squared — was described as "entirely unreliable" in predicting the risk of death over a 15-year period from any cause. The study included 4,252 people in the U.S. and pulled data from the National Health and Nutrition Examination Survey. BMI should not be relied upon as a "vital sign" of health, according to senior author Frank Orlando, M.D., medical director of UF Health Family Medicine in Springhill. "I'm a family physician, and on a regular basis, we're faced with patients who have diabetes, heart disease, obesity and other conditions that are related to obesity," Orlando said in a press release for the study. "One of the routine measures we take alongside traditional vital signs is BMI. We use BMI to screen for a person having an issue with their body composition, but it's not as accurate for everyone as vital signs are," he added. BMI has been the international standard for measuring obesity since the 1980s, according to many sources, though some experts have questioned its validity. "I think the study shows it's time to go to an alternative that is now proven to be far better at the job." An individual is considered obese if their BMI is 30 or above, overweight if it is between 25 and 29.9, of "normal" weight in the range of 18.5 to 24.9, or underweight if lower than 18.5. While BMI is easy to calculate, one of its main limitations is that it cannot distinguish between muscle and fat mass, the researchers noted. "For example, people who are bodybuilders can really elevate their body mass index," Orlando said. "But they're healthy even with a BMI indicating that they're obese." "BMI is just so ingrained in how we think about body fat," Mainous added. "I think the study shows it's time to go to an alternative that is now proven to be far better at the job." Other methods, such as a DEXA (dual-energy X-ray absorptiometry) scan, may be even more accurate than BIA, but are much more expensive and not as accessible, the researchers noted. "If you talk to obesity researchers, they're going to say you have to use the DEXA scan because it's the most accurate," Mainous said in the release. "And that's probably true. But it's never going to be viable in a doctor's office or family practice." Dr. Stephen Vogel — a family medicine physician with PlushCare, a virtual health platform with primary care, therapy and weight management options — echoed the limitations of BMI. "It has been an easy measurement tool that helps us understand at-risk groups across various populations and demographics, but it doesn't provide accurate data from patient to patient," the North Carolina-based doctor, who was not involved in the study, told Fox News Digital. "These findings don't challenge the assumptions about BMI — they strengthen the message that new standards, delivered in a consistent and low-cost way, would provide better nuance for the individual when it comes to their overall physical health." "The main strengths of this study are a better correlation to an individual's risk of morbidity and mortality — however, the limitations lie in the fact that we don't have enough data to determine the right cutoff for these numbers, or to identify the right tools that will be both accurate and precise across the population," Vogel said. The researchers also acknowledged that body fat percentage thresholds haven't yet been as standardized as BMI and waist circumference. Also, the age range of the participants in the study was limited by the data source. "Future studies should extend this comparison of body fat to BMI in older adults," the researchers wrote. The study was also limited by focusing only on mortality as an outcome, they noted, without taking into account any developing diseases — such as heart failure or cancer — that could deepen the understanding of body fat as a risk factor. The goal, according to Vogel, is to have a cost-effective, consistent method that can be used across the population with reliable accuracy. "These data will drive better discussions in the doctor's office, as well as public health initiatives with the goal of improving the health of all." "Benefits would come in the form of a more detailed list of information that helps providers and patients make informed decisions about the patient's health, which is ideal," Vogel noted. "I'm hopeful there's enough buzz around these measures that steps will continue to be taken toward regular implementation." For more Health articles, visit The researchers are hopeful that once standards are validated, measuring body fat percentage with bioelectrical impedance analysis could become standard of care. They added, "These data will drive better discussions in the doctor's office, as well as public health initiatives with the goal of improving the health of all."

Citi Expresses Optimism for Eli Lilly and Company (LLY)
Citi Expresses Optimism for Eli Lilly and Company (LLY)

Yahoo

time31 minutes ago

  • Yahoo

Citi Expresses Optimism for Eli Lilly and Company (LLY)

Eli Lilly and Company (NYSE:LLY) is one of the 13 Best Long Term Growth Stocks to Invest in Right Now. On June 25, Citi reported that 'compelling' data shows that Eli Lilly and Company (NYSE:LLY) and Novo Nordisk (NVO) have turned obesity into a treatable disease from a lifestyle-based condition. The firm models more than $40 billion in obesity sales by 2030, well above the consensus estimates of $25 billion. Citi stated that as the obesity space evolves from injectables to convenient orals, such as orforglipron, the emergence of a 'dynamic' consumer-centric market is possible, and LillyDirect by Eli Lilly and Company (NYSE:LLY) is well-positioned to connect high consumer visibility for orforglipron with global access. In a research note, Citi further stated that it estimated penetration rates via income-based tiers for pricing and out-of-pocket costs in low- and mid-body mass index patients. The results place Eli Lilly and Company's (NYSE:LLY) consumer platform opportunity at $15B, which is not assumed in the firm's model. It thus believes that Eli Lilly and Company's (NYSE:LLY) is in a position to expedite access outside the US, employing a centralized out-of-pocket payment model instead of the traditional country-by-country launch. It contended that an 'income-based tiered pricing of orforglipron via LillyDirect could unlock unprecedented volume, all the while allowing it to maintain overall pricing power.' Eli Lilly and Company (NYSE:LLY) develops, manufactures, discovers, and sells pharmaceutical products. These products span oncology, diabetes, immunology, neuroscience, and other therapies. Investors are bullish on Eli Lilly and Company (NYSE:LLY) due to its in-demand GLP-1 drugs, used to treat diabetes and obesity, which are still in their early growth stages, and the company's strong financials. While we acknowledge the potential of LKQ as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: The Best and Worst Dow Stocks for the Next 12 Months and 10 Unstoppable Stocks That Could Double Your Money. Disclosure: None. Sign in to access your portfolio

Why a G.O.P. Medicaid Requirement Could Set States Up for Failure
Why a G.O.P. Medicaid Requirement Could Set States Up for Failure

New York Times

time32 minutes ago

  • New York Times

Why a G.O.P. Medicaid Requirement Could Set States Up for Failure

The strict Medicaid work requirement at the center of the Republicans' major policy bill wouldn't just require millions of poor Americans to prove they are employed to sign up for health insurance. It would also require dozens of states to quickly build expensive and complex software systems to measure and track who is eligible. This new responsibility for states, whose existing Medicaid computer systems are often outdated, would be accompanied by reduced federal funding through other changes in the bill. The result, according to state officials, software developers and policy experts, could be major failures in state systems for enrolling people in Medicaid. 'That's how happens,' said Julie Brinn Siegel, a former top Biden administration budget official, referring to the Obama administration's botched launch of the online Affordable Care Act enrollment portal in 2013. Ms. Siegel and others familiar with Medicaid systems envision problems like websites that don't load or incorrectly tell applicants they are not eligible. And Medicaid workers may be overwhelmed as they try to run call centers and process applications. The fallout could mean eligible Americans will have their coverage dropped. Republicans contend that the work requirement achieves twin goals: It ensures that the government directs resources to Americans who are contributing to society, while saving money to help finance an extension of President Trump's tax cuts. Want all of The Times? Subscribe.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store